Comparative evaluation of three commercial identification systems using common and rare bloodstream yeast isolates

Journal of Clinical Microbiology

Volumn 49, Issue 7, 2011, Pages 2722-2727

  Meletiadis, Joseph ^a   Arabatzis, Michael ^b   Bompola, Maria ^a   Tsiveriotis, Konstantinos ^a   Hini, Stavroula ^c   Petinaki, Efthymia ^d   Velegraki, Aristea ^b   Zerva, Loukia ^a  

^a NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^c KAT HOSPITAL   (Greece)

^d UNIVERSITY OF THESSALY   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

DNA 26S;

ANALYTICAL EQUIPMENT; ARTICLE; BLOOD FLOW; CANDIDA; COMMON SPECIES; CONTROLLED STUDY; DNA SEQUENCE; FUNGAL STRAIN; FUNGUS CULTURE; FUNGUS IDENTIFICATION; FUNGUS ISOLATION; INTERMETHOD COMPARISON; MOLECULAR BIOLOGY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RARE SPECIES; SEQUENCE HOMOLOGY; SPECIES IDENTIFICATION; STRAIN IDENTIFICATION; UNINDEXED SEQUENCE;

BLOOD; FUNGEMIA; HUMANS; MICROBIOLOGICAL TECHNIQUES; MYCOLOGY; SENSITIVITY AND SPECIFICITY; YEASTS;

EID: 79959815003     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.01253-10     Document Type: Article

References (21)

1. Aubertine, C. L., M. Rivera, S. M. Rohan, and D. H. Larone. 2006. Comparative study of the new colorimetric VITEK 2 yeast identification card versus the older fluorometric card and of CHROMagar Candida as a source medium with the new card. J. Clin. Microbiol. 44:227-228.
2. Burton, M. J., P. Shah, and E. Swiatlo. 2011. Misidentification of Candida parapsilosis as Candida famata in a clinical case of vertebral osteomyelitis. Am. J. Med. Sci. 341:71-73.
3. Campbell, C. K., K. G. Davey, A. D. Holmes, A. Szekely, and D. W. Warnock. 1999. Comparison of the API Candida system with the AUXACOLOR system for identification of common yeast pathogens. J. Clin. Microbiol. 37:821-823.
4. Clinical and Laboratory Standards Institute. 2008. Interpretive criteria for identification of bacteria and fungi by DNA target sequencing: guideline. CLSI document MM18-A. Clinical and Laboratory Standards Institute, Wayne, PA.
5. Freydiere, A. M., R. Guinet, and P. Boiron. 2001. Yeast identification in the clinical microbiology laboratory: phenotypical methods. Med. Mycol. 39:9-33.
6. Groll, A. H., and T. J. Walsh. 2001. Uncommon opportunistic fungi: new nosocomial threats. Clin. Microbiol. Infect. 7(Suppl. 2):8-24.
7. Hata, D. J., L. Hall, A. W. Fothergill, D. H. Larone, and N. L. Wengenack. 2007. Multicenter evaluation of the new VITEK 2 advanced colorimetric yeast identification card. J. Clin. Microbiol. 45:1087-1092.
8. Latouche, G. N., et al. 1997. Comparison of use of phenotypic and genotypic characteristics for identification of the anamorph genus Candida and related teleomorph yeast species. J. Clin. Microbiol. 35:3171-3180.
9. Leaw, S. N., et al. 2006. Identification of medically important yeast species by sequence analysis of the internal transcribed spacer regions. J. Clin. Microbiol. 44:693-699.
10. Loïez, C., F. Wallet, B. Sendid, and R. J. Courcol. 2006. Evaluation of VITEK 2 colorimetric cards versus fluorimetric cards for identification of yeasts. Diagn. Microbiol. Infect. Dis. 56:455-457.
11. Mannarelli, B. M., and C. P. Kurtzman. 1998. Rapid identification of Candida albicans and other human pathogenic yeasts by using short oligonucleotides in a PCR. J. Clin. Microbiol. 36:1634-1641.
12. Meurman, O., A. Koskensalo, and K. Rantakokko-Jalava. 2006. Evaluation of Vitek 2 for identification of yeasts in the clinical laboratory. Clin. Microbiol. Infect. 12:591-593.
13. Mitterdorfer, G., H. K. Mayer, W. Kneifel, and H. Viernstein. 2002. Clustering of Saccharomyces boulardii strains within the species S. cerevisiae using molecular typing techniques. J. Appl. Microbiol. 93:521-530.
14. Pappas, P. G., et al. 2009. Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin. Infect. Dis. 48:503-535.
15. Pfaller, M. A., and D. J. Diekema. 2007. Epidemiology of invasive candidiasis: a persistent public health problem. Clin. Microbiol. Rev. 20:133-163.
16. Sanguinetti, M., et al. 2007. Evaluation of VITEK 2 and RapID yeast plus systems for yeast species identification: experience at a large clinical microbiology laboratory. J. Clin. Microbiol. 45:1343-1346.
17. Schuffenecker, I., A. Freydiere, H. de Montclos, and Y. Gille. 1993. Evaluation of four commercial systems for identification of medically important yeasts. Eur. J. Clin. Microbiol. Infect. Dis. 12:255-260.
18. Velegraki, A., et al. 1999. Identification of medically significant fungal genera by polymerase chain reaction followed by restriction enzyme analysis. FEMS Immunol. Med. Microbiol. 23:303-312.
19. Verweij, P. E., I. M. Breuker, A. J. Rijs, and J. F. Meis. 1999. Comparative study of seven commercial yeast identification systems. J. Clin. Pathol. 52:271-273.
20. Vijgen, S., et al. 2011. Comparison of Vitek identification and antifungal susceptibility testing methods to DNA sequencing and Sensititre YeastOne antifungal testing. Med. Mycol. 49:107-110.
21. Wisplinghoff, H., et al. 2004. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin. Infect. Dis. 39:309-317.